Efficacy and Safety of Rivastigmine in Patients With Mild Cognitive Impairment

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00134953
Recruitment Status : Terminated (The Principal Investigator left the clinic and there was no one who could take over this study.)
First Posted : August 25, 2005
Last Update Posted : December 17, 2007
Information provided by:

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Primary Completion Date : No date given
  Actual Study Completion Date : May 2004